Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Genflow Biosciences Plc LSE:GENF London Ordinary Share GB00BP2C3V08 ORD GBP0.0003
  Price Change % Change Share Price Shares Traded Last Trade
  -0.18 -5.14% 3.32 3,123,414 16:35:04
Bid Price Offer Price High Price Low Price Open Price
3.30 3.60 3.85 3.45 3.45
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 10
Last Trade Time Trade Type Trade Size Trade Price Currency
16:42:31 O 50,000 3.80 GBX

Genflow Biosciences (GENF) Latest News

More Genflow Biosciences News
Genflow Biosciences Investors    Genflow Biosciences Takeover Rumours

Genflow Biosciences (GENF) Discussions and Chat

Genflow Biosciences Forums and Chat

Date Time Title Posts
29/11/202218:05Genflow Biosciences plc 202257
28/11/202214:23Old age a thing of the past?33
15/4/202210:31US SEC indicts key shareholder-
01/2/202211:45Welcome3

Add a New Thread

Genflow Biosciences (GENF) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
16:42:313.8050,0001,900.00O
16:35:043.3250,0001,660.00UT
16:35:003.302508.25O
16:35:003.601384.97O
16:35:003.3054017.82O
View all Genflow Biosciences trades in real-time

Genflow Biosciences (GENF) Top Chat Posts

Top Posts
Posted at 29/11/2022 08:20 by Genflow Biosciences Daily Update
Genflow Biosciences Plc is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker GENF. The last closing price for Genflow Biosciences was 3.50p.
Genflow Biosciences Plc has a 4 week average price of 1.75p and a 12 week average price of 1.75p.
The 1 year high share price is 13.25p while the 1 year low share price is currently 1.75p.
There are currently 292,506,618 shares in issue and the average daily traded volume is 2,434,864 shares. The market capitalisation of Genflow Biosciences Plc is £9,711,219.72.
Posted at 28/11/2022 15:04 by moneymunch
The answer lies in a 2013 paper published in a highly regarded journal entitled “The Hallmarks of Ageing”...

To put it simply, the paper outlines 9 hallmarks of aging that provide a framework for prolonging human life. This roadmap to longevity spawned numerous biotech companies that used it as a roadmap for their R&D.

 

But even the companies regarded as the cream-of-crop are at a disadvantage…

They tend to focus on a single hallmark of aging. To quote Eric Leire, the company’s chief executive, “You’ve only solved one-ninth of the problem with this approach.”

Genflow Biosciences takes a holistic approach by targeting 4 of the 9 hallmarks directly, in addition to 2 indirectly. They are able to do this by focusing on the SIRT6 gene. This gene’s overexpression has proven to extend the lives of healthy mice, winning it the title of the “master regulator of aging”.

This novel research has allowed the company to capture alluring patents, which brings us back to Altos Labs…

If anyone wants this IP they would have to purchase the company at a significant premium to the current share price or enter a licensing agreement.

Altos Labs opened only a few months ago, in January of 2022. We know that Altos Labs has the ambition and the means to become the leader in longevity tech, and Genflow Biosciences likely holds the keys to that ambition.

It stands to reason that the mega-tech startup would team up with or outright buy Genflow Biosciences, launching its extremely undervalued share price to match, or exceed, its peer group.

Consider that on mere rumors of acquisition for their LIDAR IP, Microvision’s (MVIS) share price exploded almost 300% in less than 2 weeks last year.

Now imagine the sudden news that a Bezo’s backed company set on discovering the formula for immortality is acquiring or partnering with a little-known European biotech start-up with a share price of only 2p

 

News like this could pop at any second. Launching Genflow Biosciences into the spotlight at any time this year.

This is a highly competitive industry and players with deep pockets see Genflow Biosciences’ IP as their ticket to the top of the market. If it’s not Altos Labs, then surely there will be another. 

https://clearcapitalmarkets.co.uk/biotech-opinion-joe-neighbour/?gclid=EAIaIQobChMInZjjq4TP-wIVhLTtCh3iWQGBEAAYASAAEgIBGfD_BwE

Posted at 01/8/2022 13:53 by dave4545
2.75-2.755p spread

So now you can buy size at the bid price and a full penny lower than recent director buys.

Posted at 29/7/2022 13:51 by felchandbart
I like the look of this company. Have been invested here for a couple of weeks now, price has dropped slightly since then but clearly plenty of upside potential. Credible team and well-funded. Can't see it hanging around at these levels for too long.
Posted at 20/7/2022 07:54 by dave4545
Shame some are selling the same price directors are buying
Posted at 12/7/2022 08:59 by tomboyb
GENF is in the position where no funding is required -

Down from header 13p to 2p is a good entry imo -

Posted at 12/7/2022 08:45 by dave4545
It was 2.35p mid price yesterday, when I saw that trade today I rushed to see if smaller could get that price still but not a bean offered online so it's going to shift.

Should have took a starter yesterday as a base.

Took the NMS 30k at 2.5p, mm wanted 3p for 100k when 2.5p offer greedy or what

Posted at 12/7/2022 07:56 by tomboyb
Buzz, I think GENF have run out of sellers -

Buying and adding a few Biotech -

Posted at 11/7/2022 08:08 by manual dexterity
The difference here having looked at both CIZ and GENF is that CIZ may need funds. GENF has no requirement for fund for the foreseeable future. I do think this has been hit pretty hard, so a decent punt at these levels.
Posted at 09/6/2022 16:45 by deadly nightshade
Buzz if you go back over past few days there were some bigger trades I was trying to work out if it was a big seller and price was going down so it could go through at a certain price like 3p? It's stayed down at this range so not sure what's happening. Where do you see this company going buzz as looking back through posts you have been here from the start, are you still confident buzz?
Posted at 09/6/2022 13:31 by deadly nightshade
Any idea if we have a big seller here as share price is crashing? Someone looks to be off loading big time by the look of the trades?
Genflow Biosciences share price data is direct from the London Stock Exchange
Your Recent History
LSE
GENF
Genflow Bi..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20221129 23:50:46